Cargando…

Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study

Psychoneurological symptom clusters are co-occurring and interrelated physiological symptoms that may include cancer-related fatigue, pain, depressive symptoms, cognitive disturbances, and sleep disturbances. These symptoms are hypothesized to share a common systemic proinflammatory etiology. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sass, Dilorom, Saligan, Leorey, Fitzgerald, Wendy, Berger, Ann M., Torres, Isaias, Barb, Jennifer J., Kupzyk, Kevin, Margolis, Leonid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385103/
https://www.ncbi.nlm.nih.gov/pubmed/34429399
http://dx.doi.org/10.1038/s41398-021-01554-w
_version_ 1783742023735443456
author Sass, Dilorom
Saligan, Leorey
Fitzgerald, Wendy
Berger, Ann M.
Torres, Isaias
Barb, Jennifer J.
Kupzyk, Kevin
Margolis, Leonid
author_facet Sass, Dilorom
Saligan, Leorey
Fitzgerald, Wendy
Berger, Ann M.
Torres, Isaias
Barb, Jennifer J.
Kupzyk, Kevin
Margolis, Leonid
author_sort Sass, Dilorom
collection PubMed
description Psychoneurological symptom clusters are co-occurring and interrelated physiological symptoms that may include cancer-related fatigue, pain, depressive symptoms, cognitive disturbances, and sleep disturbances. These symptoms are hypothesized to share a common systemic proinflammatory etiology. Thus, an investigation of systemic immune biomarkers is an important approach to test this hypothesis. Here, we investigated the associations between extracellular vesicle (EV)-associated and soluble cytokines with immune markers and symptom clusters in men with non-metastatic prostate cancer. This observational study included 40 men with non-metastatic prostate cancer at the start (T1) of external beam radiation therapy (EBRT) and 3 months post treatment (T2), as well as 20 men with non-metastatic prostate cancer on active surveillance (AS) seen at one time point. Collected questionnaires assessed patient-reported fatigue, sleep disturbances, depressive symptoms, and cognitive fatigue. In total, 45 soluble and EV-associated biomarkers in plasma were determined by multiplex assays. Principal component analysis (PCA) was used to identify psychoneurological symptom clusters for each study group and their time points. Bivariate correlation analysis was run for each identified PCA cluster with the concentrations of EV-associated and soluble cytokines and immune markers. Both EV-associated and soluble forms of RANTES significantly correlated with the symptom cluster for EBRT at T1, whereas, at T2, soluble IFNα2, IL-9, and IL-17 correlated with the corresponding symptom cluster. For the AS group, soluble survivin correlated with psychoneurological symptoms. Linking specific inflammatory cytokines with psychoneurological symptom clusters in men receiving prostate cancer treatment can enhance understanding of the underlying mechanisms of this phenomenon and aid in developing targeted interventions.
format Online
Article
Text
id pubmed-8385103
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83851032021-09-14 Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study Sass, Dilorom Saligan, Leorey Fitzgerald, Wendy Berger, Ann M. Torres, Isaias Barb, Jennifer J. Kupzyk, Kevin Margolis, Leonid Transl Psychiatry Article Psychoneurological symptom clusters are co-occurring and interrelated physiological symptoms that may include cancer-related fatigue, pain, depressive symptoms, cognitive disturbances, and sleep disturbances. These symptoms are hypothesized to share a common systemic proinflammatory etiology. Thus, an investigation of systemic immune biomarkers is an important approach to test this hypothesis. Here, we investigated the associations between extracellular vesicle (EV)-associated and soluble cytokines with immune markers and symptom clusters in men with non-metastatic prostate cancer. This observational study included 40 men with non-metastatic prostate cancer at the start (T1) of external beam radiation therapy (EBRT) and 3 months post treatment (T2), as well as 20 men with non-metastatic prostate cancer on active surveillance (AS) seen at one time point. Collected questionnaires assessed patient-reported fatigue, sleep disturbances, depressive symptoms, and cognitive fatigue. In total, 45 soluble and EV-associated biomarkers in plasma were determined by multiplex assays. Principal component analysis (PCA) was used to identify psychoneurological symptom clusters for each study group and their time points. Bivariate correlation analysis was run for each identified PCA cluster with the concentrations of EV-associated and soluble cytokines and immune markers. Both EV-associated and soluble forms of RANTES significantly correlated with the symptom cluster for EBRT at T1, whereas, at T2, soluble IFNα2, IL-9, and IL-17 correlated with the corresponding symptom cluster. For the AS group, soluble survivin correlated with psychoneurological symptoms. Linking specific inflammatory cytokines with psychoneurological symptom clusters in men receiving prostate cancer treatment can enhance understanding of the underlying mechanisms of this phenomenon and aid in developing targeted interventions. Nature Publishing Group UK 2021-08-24 /pmc/articles/PMC8385103/ /pubmed/34429399 http://dx.doi.org/10.1038/s41398-021-01554-w Text en © This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Sass, Dilorom
Saligan, Leorey
Fitzgerald, Wendy
Berger, Ann M.
Torres, Isaias
Barb, Jennifer J.
Kupzyk, Kevin
Margolis, Leonid
Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study
title Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study
title_full Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study
title_fullStr Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study
title_full_unstemmed Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study
title_short Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study
title_sort extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385103/
https://www.ncbi.nlm.nih.gov/pubmed/34429399
http://dx.doi.org/10.1038/s41398-021-01554-w
work_keys_str_mv AT sassdilorom extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy
AT saliganleorey extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy
AT fitzgeraldwendy extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy
AT bergerannm extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy
AT torresisaias extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy
AT barbjenniferj extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy
AT kupzykkevin extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy
AT margolisleonid extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy